AU575951B2 - Insulin preparation with thickening agent and surfactant - Google Patents
Insulin preparation with thickening agent and surfactantInfo
- Publication number
- AU575951B2 AU575951B2 AU43424/85A AU4342485A AU575951B2 AU 575951 B2 AU575951 B2 AU 575951B2 AU 43424/85 A AU43424/85 A AU 43424/85A AU 4342485 A AU4342485 A AU 4342485A AU 575951 B2 AU575951 B2 AU 575951B2
- Authority
- AU
- Australia
- Prior art keywords
- plunger pipe
- plate
- damper
- sealing plate
- pipe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Luminescent Compositions (AREA)
- Steroid Compounds (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
1. Pulsation damper (10) for elastically disposed objects (26), including a damper housing which is at least partially filled with 3 viscose damping medium (12) and which is open at the top relative to its installation position ; a hollow plunger pipe (17) which is open at the bottom relative to its installation position and continuously conically formed and which can be moved up and down into the damper medium (12) ; a top plate (16), linked with the plunger pipe (17), for receiving the object (26), in which respect the plunger pipe (17) is connected with the top plate (16) by its smaller diameter (28), and its larger diameter (29) is emersed into the damper medium (12), characterised in that the interior of the plunger pipe (17) is divided into two chambers by a sealing plate (22) ; that a buffer plate (24) including passages (33) is disposed in the larger diameter (29) at the bottom of the plunger pipe (17) which plate carries a plurality of interior pipes (21) which extend into the plunger pipe (17), the upper ends of the interior pipes (21) being at a distance (35) from the sealing plate (22), and the plunger pipe (17) has a plurality of peripheral bores (19) in the casing surface below the sealing plate (22).
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3421615 | 1984-06-09 | ||
DE3421613 | 1984-06-09 | ||
DE3421615 | 1984-06-09 | ||
DE3421613 | 1984-06-09 | ||
DE19843443877 DE3443877A1 (en) | 1984-06-09 | 1984-12-01 | Insulin preparations, process for their preparation, and their use |
DE3443877 | 1984-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4342485A AU4342485A (en) | 1985-12-12 |
AU575951B2 true AU575951B2 (en) | 1988-08-11 |
Family
ID=27192050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43424/85A Expired AU575951B2 (en) | 1984-06-09 | 1985-06-07 | Insulin preparation with thickening agent and surfactant |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0166971B1 (en) |
AT (1) | ATE50502T1 (en) |
AU (1) | AU575951B2 (en) |
CA (1) | CA1258427A (en) |
DE (1) | DE3576120D1 (en) |
DK (1) | DK162255C (en) |
ES (1) | ES8605679A1 (en) |
FI (1) | FI80596C (en) |
GR (1) | GR851393B (en) |
HU (1) | HU200102B (en) |
IE (1) | IE57998B1 (en) |
IL (1) | IL75448A (en) |
NO (1) | NO164277C (en) |
NZ (1) | NZ212338A (en) |
PH (1) | PH24118A (en) |
PT (1) | PT80620B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO179479C (en) * | 1988-03-11 | 1996-10-16 | Teikoku Seiyaku Kk | Process for the preparation of an intravaginal pharmaceutical preparation |
DE10114178A1 (en) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinc-free and low-zinc insulin preparations with improved stability |
DE10227232A1 (en) * | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Sour insulin preparations with improved stability |
KR101820024B1 (en) | 2008-10-17 | 2018-01-18 | 사노피-아벤티스 도이칠란트 게엠베하 | Combination of an insulin and a GLP-1 agonist |
LT2498801T (en) | 2009-11-13 | 2018-05-10 | Sanofi-Aventis Deutschland Gmbh | PHARMACEUTICAL COMPOSITION COMPRISING desPro36Exendin-4(1-39)-Lys6-NH2 AND METHIONINE |
PL3417871T3 (en) | 2009-11-13 | 2021-06-14 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical composition comprising a glp-1-agonist, an insulin, and methionine |
MX339614B (en) | 2010-08-30 | 2016-06-02 | Sanofi - Aventis Deutschland GmbH | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2. |
US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
CN110354255B (en) | 2013-04-03 | 2024-05-14 | 赛诺菲 | Treatment of diabetes by long acting insulin formulations |
CA2970200A1 (en) | 2014-12-12 | 2016-06-16 | Sanofi-Aventis Deutschland Gmbh | Insulin glargine/lixisenatide fixed ratio formulation |
TWI748945B (en) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | Treatment type 2 diabetes mellitus patients |
TW201705975A (en) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | Treatment of type 2 diabetes mellitus patients |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4292585A (en) * | 1984-04-30 | 1985-11-28 | Trustees Of Columbia University In The City Of New York, The | Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch |
AU549981B2 (en) * | 1982-02-05 | 1986-02-20 | Novo Nordisk A/S | Zinc stabilized insulin |
AU552054B2 (en) * | 1981-08-27 | 1986-05-22 | Eli Lilly And Company | Human proinsulin compositions |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2474729A (en) * | 1945-01-03 | 1949-06-28 | Rhone Poulenc Sa | Insulin preparations |
US2574889A (en) * | 1947-10-06 | 1951-11-13 | Leo Ab | Methylated gelatin-insulin preparation |
SU1011126A1 (en) * | 1981-07-14 | 1983-04-15 | Всесоюзный научно-исследовательский и испытательный институт медицинской техники | Method of treating diabetes mellitus |
-
1985
- 1985-05-30 AT AT85106669T patent/ATE50502T1/en not_active IP Right Cessation
- 1985-05-30 EP EP85106669A patent/EP0166971B1/en not_active Expired - Lifetime
- 1985-05-30 DE DE8585106669T patent/DE3576120D1/en not_active Expired - Lifetime
- 1985-06-04 HU HU852203A patent/HU200102B/en unknown
- 1985-06-06 FI FI852273A patent/FI80596C/en not_active IP Right Cessation
- 1985-06-06 DK DK254585A patent/DK162255C/en not_active IP Right Cessation
- 1985-06-07 IL IL75448A patent/IL75448A/en not_active IP Right Cessation
- 1985-06-07 IE IE1431/85A patent/IE57998B1/en not_active IP Right Cessation
- 1985-06-07 PH PH32375A patent/PH24118A/en unknown
- 1985-06-07 CA CA000483496A patent/CA1258427A/en not_active Expired
- 1985-06-07 ES ES543972A patent/ES8605679A1/en not_active Expired
- 1985-06-07 NZ NZ212338A patent/NZ212338A/en unknown
- 1985-06-07 AU AU43424/85A patent/AU575951B2/en not_active Expired
- 1985-06-07 NO NO852314A patent/NO164277C/en unknown
- 1985-06-07 PT PT80620A patent/PT80620B/en unknown
- 1985-06-07 GR GR851393A patent/GR851393B/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU552054B2 (en) * | 1981-08-27 | 1986-05-22 | Eli Lilly And Company | Human proinsulin compositions |
AU549981B2 (en) * | 1982-02-05 | 1986-02-20 | Novo Nordisk A/S | Zinc stabilized insulin |
AU4292585A (en) * | 1984-04-30 | 1985-11-28 | Trustees Of Columbia University In The City Of New York, The | Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch |
Also Published As
Publication number | Publication date |
---|---|
DK162255C (en) | 1992-03-16 |
NO164277B (en) | 1990-06-11 |
IE57998B1 (en) | 1993-06-02 |
FI852273A0 (en) | 1985-06-06 |
PH24118A (en) | 1990-03-05 |
PT80620B (en) | 1987-10-20 |
CA1258427A (en) | 1989-08-15 |
EP0166971B1 (en) | 1990-02-28 |
AU4342485A (en) | 1985-12-12 |
ES543972A0 (en) | 1986-01-16 |
DK254585D0 (en) | 1985-06-06 |
NO852314L (en) | 1985-12-10 |
IE851431L (en) | 1985-12-09 |
DK254585A (en) | 1985-12-10 |
FI80596B (en) | 1990-03-30 |
NZ212338A (en) | 1989-02-24 |
HUT37893A (en) | 1986-03-28 |
PT80620A (en) | 1985-07-01 |
ATE50502T1 (en) | 1990-03-15 |
IL75448A0 (en) | 1985-10-31 |
HU200102B (en) | 1990-04-28 |
FI80596C (en) | 1990-07-10 |
ES8605679A1 (en) | 1986-01-16 |
GR851393B (en) | 1985-11-25 |
NO164277C (en) | 1990-09-19 |
DE3576120D1 (en) | 1990-04-05 |
FI852273L (en) | 1985-12-10 |
DK162255B (en) | 1991-10-07 |
EP0166971A1 (en) | 1986-01-08 |
IL75448A (en) | 1989-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU575951B2 (en) | Insulin preparation with thickening agent and surfactant | |
JPS57191127A (en) | Engine mount filled with fluid | |
IE822770L (en) | Bulk container | |
ES8608163A1 (en) | Apparatus for the cryofixation of specimens. | |
JPS5776340A (en) | Liquid sealed-in vibration-proof apparatus | |
CY2432B1 (en) | System for sealingly mounting a miniature pump onto a little container. | |
DE69010781D1 (en) | Device for chest drainage. | |
GB2185087A (en) | Shock absorber | |
DE59906300D1 (en) | Fluid shock absorber | |
ATE44503T1 (en) | ENERGY ABSORBER. | |
FR2456260A1 (en) | Antivibration mounting between machine and baseplate - is inverted rubber cup with wall which has double deflection characteristic for greater stability | |
ES2048369T3 (en) | LIQUID METAL TREATMENT. | |
ATE43384T1 (en) | PIPE SEPARATOR. | |
SU1779088A1 (en) | Deflecting device | |
JPS5576238A (en) | Automobile damper | |
ES257901U (en) | Tomamuestras head for blood sedimentation speed meter. (Machine-translation by Google Translate, not legally binding) | |
CA2086702A1 (en) | Blowing lance suspension with integrated medium supply | |
CA2226551A1 (en) | Sealing and guiding device for the injection piston of a hot chamber pump for corrosive alloys | |
MY101782A (en) | Method for removing a volatile material from a liquid and equipment for the working of this method | |
IT1235157B (en) | Suspension in a rubber sleeve with hydraulic dampening, in particular for machine parts | |
DE3273037D1 (en) | Horizontal chamber coke oven | |
UA39943C2 (en) | ENERGY COMPENSATOR | |
UA12022A1 (en) | Pipette |